Singapore markets closed
Straits Times Index
3,410.81 -29.07 (-0.85%) Nikkei
40,912.37 -1.28 (-0.00%) Hang Seng
17,799.61 -228.67 (-1.27%) FTSE 100
8,203.93 -37.33 (-0.45%) Bitcoin USD
56,547.39 -1,719.93 (-2.95%) CMC Crypto 200
1,166.71 -41.99 (-3.48%)
Santen Pharmaceutical Co., Ltd. (SZD.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:05AM CEST. Market open.
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 3.49B |
| Enterprise value | 2.94B |
| Trailing P/E | 23.14 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.04 |
| Price/book (mrq) | 1.97 |
| Enterprise value/revenue | 1.70 |
| Enterprise value/EBITDA | 10.11 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.20 |
| 52-week change 3 | 28.00% |
| S&P500 52-week change 3 | 25.87% |
| 52-week high 3 | 9.75 |
| 52-week low 3 | 7.35 |
| 50-day moving average 3 | 9.34 |
| 200-day moving average 3 | 8.89 |
Share statistics
| Avg vol (3-month) 3 | 34 |
| Avg vol (10-day) 3 | 34 |
| Shares outstanding 5 | 359.4M |
| Implied shares outstanding 6 | 363.07M |
| Float 8 | 334.79M |
| % held by insiders 1 | 2.79% |
| % held by institutions 1 | 49.91% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.2 |
| Forward annual dividend yield 4 | 2.13% |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | 2.18 |
| Payout ratio 4 | 45.60% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 27 Sept 2024 |
| Last split factor 2 | 5:1 |
| Last split date 3 | 27 Mar 2015 |
Financial highlights
Currency in JPY.Fiscal year
| Fiscal year ends | 31 Mar 2024 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 8.82% |
| Operating margin (ttm) | 20.25% |
Management effectiveness
| Return on assets (ttm) | 7.61% |
| Return on equity (ttm) | 8.92% |
Income statement
| Revenue (ttm) | 301.96B |
| Revenue per share (ttm) | 823.04 |
| Quarterly revenue growth (yoy) | -0.20% |
| Gross profit (ttm) | N/A |
| EBITDA | 70.36B |
| Net income avi to common (ttm) | 26.64B |
| Diluted EPS (ttm) | 0.41 |
| Quarterly earnings growth (yoy) | -97.40% |
Balance sheet
| Total cash (mrq) | 94.96B |
| Total cash per share (mrq) | 261.62 |
| Total debt (mrq) | 34.61B |
| Total debt/equity (mrq) | 11.33% |
| Current ratio (mrq) | 2.55 |
| Book value per share (mrq) | 843.18 |
Cash flow statement
| Operating cash flow (ttm) | 72.65B |
| Levered free cash flow (ttm) | 57.45B |
© 2024 Yahoo. All rights reserved.